Filed with ASX · · 2 pages · English
Epiminder Ltd. announced that the Centers for Medicare & Medicaid Services has finalized the payment rate for the Minder System implant procedure for the upcoming year, which is a significant increase from the previous rate. This new payment rate will provide hospitals with a predictable reimbursement when performing the Minder procedure in an outpatient setting, effective from the start of the year. The announcement highlights the importance of this payment determination for the company's commercial launch in the US market, as it supports the adoption of their innovative epilepsy monitoring technology.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
CMS Increases Medicare Payment for the Minder® System for CY 2027 Highlights: ? The Centers for Medicare & Medicaid Services (‘CMS’ or ‘Medicare’) has ?nalised the CY 2027 Hospital Outpatient Prospective Payment System (OPPS) rule, assigning the Minder System implant procedure to...
Follow Epiminder into a list and get an email when it puts out news.
Follow Epiminder